Summary
Forty three patients, admitted to the department of Neurological Surgery for management of central nervous system tumours, were studied pre-operatively for serum myelin basic protein immunoreactivity as a marker of central nervous system lesion and for circulating immunoglobulins and complement (C3) levels. Myelin basic protein concentration did not appear to correlate with tumour type or grade. Serum immunoglobulin levels were found to be within the normal range but the mean IgM level was significantly higher in the glioma group when compared with meningiomas.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cohen SR, McKhann GM, Guarnieri M: A radioimmunoassay for myelin basic protein and its use of quantitative measurements. J Neurochem 25:371–376, 1975.
Thomas DGT, Palfreyman JW, Ratcliffe JG: Serum myelin basic protein assay in diagnosis and prognosis of patients with head injury. Lancet i:113–115, 1978.
Palfreyman JW, Johnstone RV, Ratcliffe JG, Thomas DGT, Forbes CD: Radioimmunoassay of serum myelin basic protein and its application to patients with cerebrovascular accident. Clin Chim Acta 92:403–409, 1979.
Tokumaru T, Catalano LW Jr: Elevation of serum immunoglobulin M(IgM) in patients with brain tumours. Surg Neurol 4:17–21, 1975.
Maheley MS, Brooks WH, Roszman TL, Bigner DD, Dudka L, Richardson S: Immunobiology of primary intracranial tumours, Part 1. Studies of the cellular and humoral general immune competence of brain tumour patients. J Neurosurg 46:467–476. 1977.
Hekim N, Sayin E, Demirkaya E, Berkay F: Serum IgM level as an index of malignancy in brain tumours. Acta Neurochir 59:227–230, 1981.
Zulch KJ: Histological typing of tumours of the central nervous system. Int Histological Classif Tumours 21, 227–230, 1979
Phillips JP, Sujatanoud M, Martuza RL, Quindlen EA, Wood WC, Kornblith PL, Dohan FC Jr: Cytotoxic antibodies in preoperative patients: A diagnostic assay. Acta Neurochir 35:43–52, 1976.
Kornblith PL, Dohan FC Jr, Wood WC, Whitman BO: Human astrocytoma: Serum-mediated immunologic response. Cancer 33:1512–1519, 1974.
Garson JA, Quindlen EA, Kornblith PL: Identification of immunoglobulin classes responsible for humoral immunity to human gliomas. Surg Forum 30:461–463, 1979.
Kung PC, Lee JC, Bekay L: Vascular invasion by glioma cells in man: An electron microscopic study. J Neurosurg 31:339–345, 1969.
Tabuchi K, Kawakami Y, Nishimoto A: Immunohistochemical demonstration of IgG in meningioma. Acta Neurochir 55:201–211, 1981.
Budka H: Hyaline inclusions (pseudopsammoma bodies) in meningiomas: Immunocytochemical demonstration of epithel-like secretion of secretory component and immunoglobulins A and M. Acta Neuropathol (Berl) 56:294–298, 1982.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Seeldrayers, P., Hoyle, N. & Thomas, D. Serum MBP immunoreactivity and immunoglobulin level as markers of tumour type. J Neuro-Oncol 2, 141–145 (1984). https://doi.org/10.1007/BF00177900
Issue Date:
DOI: https://doi.org/10.1007/BF00177900